Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1215/week)
Manufacturing
(633/week)
Energy
(446/week)
Technology
(1147/week)
Other Manufacturing
(429/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Sertraline
Mar 26, 2020
2020 Sertraline Markets: Trends & Developments, Major Players, Patents, and More
Feb 20, 2020
Researchers Say Extended Antidepressant Use Creates Physical Dependence
Jan 08, 2020
Are some antidepressants less risky for pregnant women?
Jan 08, 2020
Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201
Dec 27, 2019
Pivotal Phase 3 Study of DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia Disorder Published in JAMA Network Open
Oct 04, 2019
Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA® (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress
Sep 27, 2019
Three New Analyses of Data Expand Understanding of the Potential Role for Investigational Agent Lemborexant in Insomnia and Irregular Sleep-Wake Rhythm Disorder
Jun 11, 2019
Extensive Analyses of Phase 3 Data for Investigational Lemborexant Assess Efficacy and Safety Profile for the Potential Treatment of Insomnia in Adults
Mar 27, 2019
Upsher-Smith Launches Generic Version Of Prozac® (fluoxetine) Tablets
Mar 26, 2019
Astellas Presents Fezolinetant Phase 2b Clinical Trial Results at Endocrine Society's Annual Meeting (ENDO)
Nov 21, 2018
Antidepressant Drugs Market to Reach $15.98 Bn by 2023, Globally at 2.1% CAGR, Says Allied Market Research
Sep 21, 2018
Janssen Announces Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression
May 21, 2018
New England Journal of Medicine Publishes Two Positive Phase 3 Trials Showing DUPIXENT® (dupilumab) Improved Moderate-to-Severe Asthma
May 05, 2018
New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression
Apr 25, 2018
Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions
Dec 28, 2017
Esketamine Phase 2 Data Published in JAMA Psychiatry Showed Significant Improvement of Depressive Symptoms in People with Treatment-Resistant Depression
Aug 28, 2017
Lenvatinib Significantly Improved Overall Survival in Older Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer According to Results of Subanalysis of Phase 3 SELECT Trial
Aug 17, 2017
Palo Alto Health Sciences Names Amy Perry to Board of Directors
Jun 20, 2017
Shire plc: U.S. FDA Approves Mydayis[TM] (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older
Latest News
Feb 19, 2025
Arthur D. Little Study Establishes Precise Impact of AI on Development and Engineering and Outlines Concrete...
Feb 19, 2025
Nidec Announces Its Submission of Answers to the Second Questionnaire from Makino Milling Machine Co., Ltd. (...
Feb 19, 2025
Civeo Announces Fourth Quarter 2024 Earnings Conference Call
Feb 19, 2025
Rocket Lab Successfully Launches 60th Electron, First of Multiple Missions for BlackSky
Feb 19, 2025
Energy Transfer LP Announces Pricing of $3.0 Billion of Senior Notes
Feb 19, 2025
Delek US Holdings, Inc. Announces Quarterly Dividend
Feb 19, 2025
Impulse Unveils Revolutionary Battery-Integrated Power Electronics Platform at KBIS 2025, Announces...
Feb 19, 2025
Valaris Announces Fleet Rationalization and Issues Fleet Status Report
View all News
Agenda
13
May
United States of America
Westin Lake Las Vegas Resort and Spa, Henderson, NV
Air Dominance Summit, May 13 - 14, 2025, Westin Lake Las Vegas Resort and Spa, Henderson, NV
Air Dominance Summit | May 13 - 14, 2025 | Westin Lake Las Vegas Resort and Spa, Henderson, NV SECURING AIR SUPREMACY...
29
April
Denmark
Copenhagen, Denmark
Arctic Security conference, 29-30 April 2025, Copenhagen, Denmark
Arctic Security conference | 29-30 April 2025 | Copenhagen, Denmark Defence iQ are proud to present Arctic Security...
24
March
United Kingdom
Millennium Gloucester Hotel and Conference Centre, London
Deployed Medical & Healthcare Delivery, 24 - 25 March 2025, Millennium Gloucester Hotel and Conference Centre, London
Deployed Medical & Healthcare Delivery | 24 - 25 March, 2025 |Millennium Gloucester Hotel and Conference Centre,...
View All Events